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Abstract 31 
 32 
The presence of synthetic glucocorticoids within the aquatic environment has been 33 
highlighted as a potential environmental concern as they may mimic the role of endogenous 34 
glucocorticoids during vertebrate ontogeny. Prednisolone is a commonly prescribed synthetic 35 
glucocorticoid which has been repeatedly detected in the environment. This study 36 
investigated the impact of environmentally relevant concentrations of prednisolone (0.1, 1 & 37 
10 µg/l) during zebrafish embryogenesis using physiological and behavioural endpoints 38 
which are known to be mediated by endogenous glucocorticoids. The frequency of 39 
spontaneous muscle contractions (24 hpf) was significantly reduced by prednisolone and 0.1 40 
µg/l increased the distance embryos swam in response to a mechanosensory stimulus (48 41 
hpf). The percentage of embryos hatched significantly increased following prednisolone 42 
treatment (1 & 10 µg/l), while growth and mortality were unaffected. The onset of heart 43 
contraction was differentially affected by prednisolone while heart rate and oxygen 44 
consumption both increased significantly throughout embryogenesis. No substantial effect on 45 
the axial musculature was observed. Morphological changes to the lower jaw were detected at 46 
96 hpf in response to 1 µg/l of prednisolone. Several parameters of swim behaviour were also 47 
significantly affected. Environmentally relevant concentrations of prednisolone therefore 48 
alter early zebrafish ontogeny and significantly affect embryo behaviour.  49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
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Introduction 63 
 64 
The presence of pharmaceuticals within the aquatic environment has emerged as a significant 65 
contributing factor to the degradation of aquatic ecosystems.
1,2
 However, the majority of 66 
toxicological studies which have attempted to assess the environmental impact of 67 
pharmaceuticals have largely overlooked synthetic glucocorticoids (SGs).
2,3
 Synthetic 68 
glucocorticoids are used in treating a variety of autoimmune and inflammatory diseases
4
 and 69 
are often excreted without being transformed into inactive metabolites
3
. The addition of 70 
chlorine and fluorine molecules is a common feature of SGs which increases their stability 71 
and so may also increase their longevity within the environment.
4
 Breakdown of SGs can also 72 
yield secondary compounds which are in fact more toxic than parent molecules.
5
 Considering 73 
the large quantities of these compounds which are prescribed annually
6
, and the relatively 74 
low removal rates of specific SGs from sewage management sites
7
, chronic exposure to SGs 75 
may potentially produce significant toxic effects during early development. Therefore, SGs 76 
have been highlighted as a priority for future toxicological testing.
8
 77 
   78 
Prednisolone is the second most commonly prescribed SG in the UK
8
 and has been detected 79 
within the aquatic environment at relatively low concentrations
9
. Schriks et al.
6
 found 80 
concentrations of prednisolone within industrial and hospital waste water ranged between 81 
approximately 0.25 and 2 µg/l. Prednisolone has also been reported to have a relatively low 82 
removal rate from sewage treatment plants compared to other commonly occurring SGs; 83 
around 20% less.
7
 Prednisolone was first prioritised for toxicological analysis by Besse and 84 
Garric
10
 based upon the potential environmental risk and yet few studies have since attempted 85 
to assess its toxicity. Concentrations of prednisolone as low as 1 µg/l have been shown to 86 
significantly decrease the number of leukocytes within adult fathead minnows (Pimephales 87 
promelas) and significantly increase plasma glucose levels.
11
 These changes are analogous to 88 
those effects associated with cortisol, the principal glucocorticoid in fish.
12
 Synthetic 89 
glucocorticoids therefore appear to mimic the role of endogenous hormones. Synthetic 90 
glucocorticoids are potent glucocorticoid receptor (GR) agonists which allows them to 91 
directly affect the transcription and expression of specific GR mediated genes.
13-15
 The 92 
effects of SGs may be particularly pronounced during early ontogeny which is dependent 93 
upon endogenous glucocorticoid signalling; cortisol is known to regulate several key 94 
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physiological processes such as circadian rhythmicity
16
, metabolism
17,18
 and growth
19,20 
95 
during early life stages.  96 
 97 
Endogenous glucocorticoids play a particularly prominent role during musculoskeletal 98 
development in vertebrates and are responsible for regulating muscle mass
21,22 
and bone 99 
density
23
. Sustained exposure to elevated glucocorticoid levels is associated with skeletal 100 
muscle atrophy
22
, an increase in the expression of myostatin, a negative regulator of muscle 101 
mass
21
 and increased bone resorption and decreased osteoblast production, leading to 102 
osteoporosis
24
. Knockout of GR in zebrafish (Danio rerio) causes a delay in the formation of 103 
somites which display a misshapen phenotype and is associated with a reduction in the 104 
expression of several bone morphogenetic proteins.
25
 The SG dexamethasone significantly 105 
alters craniofacial development during embryogenesis in zebrafish due to altered matrix 106 
metalloproteinase (MMP) expression.
13,14
 107 
 108 
Non-functional zebrafish GR morphants are also associated with a reduced swim activity 109 
phenotype.
26
 Glucocorticoid mediated alterations to the development of the musculoskeletal 110 
system may therefore have a direct impact upon swimming behaviour. In addition, indirect 111 
effects may also occur. Paralysis, associated with neuromuscular disorders and muscular 112 
myopathies is connected with a reduction in the mineralisation of bone.
27,28
 Indeed, 113 
contraction of the muscle fibres is not only required for subsequent development of the 114 
muscle tissue
29
 but is also necessary during ossification
30
. Studies have demonstrated that 115 
swim training may accelerate the rate of ossification during development in fish.
31,32
 116 
Therefore, the musculoskeletal system may not only be susceptible to SGs directly through 117 
developmental changes but also indirectly caused by knock on effects via alterations to 118 
individual components of the musculoskeletal system and behaviour. Consequently, 119 
analysing changes to the ontogeny of swim behaviour may offer an insightful means of 120 
assessing the impact of SGs on the musculoskeletal system.         121 
 122 
The zebrafish embryological model offers several advantages to investigate the effects of 123 
prednisolone during early development. The onset of endogenous glucocorticoid production 124 
i.e. cortisol, has already been characterised
33,34
, the expression of those hormones responsible 125 
for regulating cortisol production has also been studied
35
 and GRs identified
36
. Pikulkaew et 126 
al.
37
 found that the maternally inherited gr transcript is the most abundant transcript inherited 127 
which encodes for nuclear and membrane steroid receptors. Glucocorticoid signalling is 128 
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therefore vital during early zebrafish development and is essential for several specific 129 
developmental processes including neural, vascular and visceral organ development.
37
 The 130 
development of the musculoskeletal system of zebrafish has also been extensively 131 
characterised
38-41
 and has been utilised as a model system to investigate muscular dystrophies 132 
in other vertebrates
42,43
. In addition, the rapid development of the axial musculature and 133 
associated skeleton facilitates an extensive behavioural repertoire during embryogenesis in 134 
zebrafish. 135 
 136 
Understanding the physiological effects of prednisolone exposure during early ontogeny in 137 
zebrafish may simultaneously reveal the potential environmental impact of SG 138 
pharmaceuticals within the aquatic environment, as well as contributing to our understanding 139 
of the function of endogenous glucocorticoids during vertebrate development. Therefore, the 140 
aim of this study was to explore the potential physiological and behavioural impact of 141 
exposure to environmentally relevant concentrations of prednisolone during zebrafish 142 
embryogenesis. We use Balon's
44
 classification of early life stages of fishes, in which the 143 
transition from embryo to larva is defined by the onset of exogenous feeding. All 144 
experimentation was conducted using embryos.  145 
 146 
 147 
Methods 148 
 149 
Embryo collection 150 
Adult zebrafish from an existing stock at the University of the West of Scotland (UWS) were 151 
maintained in 25 l glass aquaria (28±1°C; 12:12 light-dark) in a 400 l re-circulatory system 152 
which used charcoal filtered tap water. Fish were fed twice daily with flake (AQUARIAN) 153 
and once daily with Artemia sp. nauplii ad libitum. Males and females were separated prior to 154 
spawning when they were mixed within a breeding net allowing collection of embryos.  155 
 156 
 157 
Exposure protocol 158 
Embryos were exposed to 0.1, 1 and 10 µg/l of prednisolone (Sigma, CAS 50-24-8) which 159 
represents the upper limits of environmentally relevant concentrations of SGs
6
. Ethanol was 160 
used as a carrier solvent and stock solutions were made in 100% ethanol (Analytical grade, 161 
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Sigma, CAS 64-17-5) immediately prior to use and were kept in the dark (4°C). Water and 162 
ethanol controls (0.01% ethanol) were also tested. All embryos were continually exposed 163 
following fertilisation (from the 2-cell stage) in groups of 50 embryos using static exposures 164 
with partial renewal (50%) every 24 h. The 50% of solution which was removed daily was 165 
frozen (-20°C) for chemical analysis. A 100 ml volume of system water (water from adult 166 
fish systems) was used as an exposure medium for the majority of testing, however, for the 167 
purposes of improving survivability into later stages of development, groups of embryos 168 
(including controls) which were used to investigate musculoskeletal and behavioural 169 
parameters were exposed to prednisolone from the 2-cell stage in 50 ml of embryo media (5 170 
mM NaCl, 0.17 mM KCl, 0.33 mM MgSO4.7H20, 0.33 mM CaCl2.2H2O and 10
-5
% of 171 
methylene blue in distilled water)
45
.All embryos were maintained at 28±1°C using water 172 
baths and any embryos which failed to develop normally were removed daily and mortality 173 
was recorded. 174 
 175 
In the event that dechorination was required to measure specific endpoints before hatching 176 
had occurred, only dechorinated embryos were used. Similarly, in the event that freely 177 
hatched embryos were required, only freely hatched embryos were used. In both cases, this 178 
ensured comparisons between treatments were made on individuals which were at the same 179 
stage of development. Replication varied between the individual parameters measured and is 180 
therefore stated in the relevant section of the methods, however, a minimum of three beaker 181 
replicates of each experimental treatment were tested for all parameters.  182 
 183 
 184 
Chemical analysis 185 
Water samples were analysed at the University of Santiago de Compostela (USC), Spain via 186 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) using a previously 187 
developed method for analysing pharmaceuticals including corticosteroids
46
. Water samples 188 
(25 ml) were filtered under vacuum using a 0.47-µm glass microfiber filter, from Filter-Lab 189 
(La Rioja, ES). Filtered samples were acidified with 0.1 N-HCl solution to a pH of 3 and 10 190 
µl of the IS solution (1 µg/ml) were added. The samples were shaken and transferred into 191 
Strata®-X SPE cartridges that were conditioned with 4 ml of methanol (CAS 67-56-1) and 4 192 
ml of Milli-Q water. The samples were loaded into the cartridges at a flow rate of 1 ml/min. 193 
Cartridges were dried under vacuum for 30 min. The sample vessels were rinsed with 4 ml of 194 
methanol which was transferred to the SPE cartridges and was left to soak for 5 min; the 195 
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eluent was collected in a 10 ml conical graduated glass Pyrex® tube (16.5×110 mm) with 4 196 
ml additional methanol. The final extract was evaporated under nitrogen at 45°C. The dried 197 
extracts were reconstituted with 200 µl of 0.1% formic acid (CAS 64-18-1) in methanol, 198 
vortexed and transferred into a 300 µl glass insert and fused into an amber 2 ml screw top 199 
standard vial (12×32 mm). The extracts were stored at -20°C until further analysis by LC-200 
MS/MS. 201 
 202 
Samples were analysed on a LC-MS/MS system consisting of an HPLC 1100 separation 203 
module from Agilent Technologies (Waldbronn, Germany), a Qtrap 2000™ mass 204 
spectrometer from Applied Biosystems/MDS Sciex (Toronto,Canada) equipped with a 205 
TurboIonSpray® source, and the Software Analyst 1.4.1 from Applied Biosystems. The 206 
chromatographic analyses were performed by injecting 10 µl of extract into a Synergi 2.5 µm 207 
Polar-RP 100A column (50×2.0 mm) connected to a Polar-RP security-guard cartridge 208 
(4.0×2.0 mm), both obtained from Phenomenex (Macclesfield, UK). Separation of analytes 209 
was achieved using a gradient mixture of two components, 0.1% formic acid in acetonitrile 210 
(CAS 75-05-8) and 0.1% formic acid in water. The gradient programme is reported in 211 
Iglesias et al.
46
  212 
 213 
Mass-spectrometry (MS) measurements were performed using positive electrospray, and drug 214 
identification was performed using two multiple reaction monitoring transitions and their 215 
retention times. The following MS parameters were utilised for prednisolone measurements: 216 
declustering potential, 21; entrance potential, 6; collision cell entrance potential, 14; collision 217 
energy, 29 and cell exit potential, 4. A source temperature of 400°C, a vacuum gauge of 218 
22×10
4
 Pa, an ion spray voltage of 5.5 V and a curtain gas pressure of 17×10
4 
Pa were 219 
maintained throughout. The first ion source was set at 38×10
4 
Pa, and the second ion source 220 
at 34×10
4
 Pa. For all monitored transitions, the dwell time was 10 ms. 221 
 222 
The limits of detection and quantification were 12.5 and 25 ng/l. Preliminary testing found 223 
that samples collected at 0 h were 0.1±0.05, 1.1±0.63 and 8.2±0.45 µg/l. No prednisolone 224 
was detected within either control group. Unfortunately, the majority of samples collected 225 
throughout the experiment defrosted in transit between UWS and USC which caused 226 
degradation of the samples. Results are therefore discussed in terms of nominal 227 
concentrations of prednisolone at the start of exposure.      228 
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 229 
 230 
Pre-hatch activity 231 
The onset of pre-hatch activity was monitored at 15, 16 and 17 hours post fertilisation (hpf). 232 
Embryos were visualised in the chorion within the beakers in which they were maintained 233 
under a dissection microscope. Care was taken not to cause any sudden vibrations along the 234 
bench which could cause a startle response during observation. Embryos were observed for 1 235 
minute after an initial 1 minute acclimation period. The percentage of embryos which 236 
displayed stereotypic body contractions at each time point was recorded. Four beaker 237 
replicates of each experimental treatment were visualised (n = 4). The frequency of 238 
spontaneous contractions at 24 hpf was also recorded using four embryos from each of the 239 
four treatment replicates (n = 16). Embryos were observed for 3 minutes after an initial 1 240 
minute acclimation period and the mean number of contractions was calculated per minute 241 
(contractions per minute, cpm). 242 
 243 
 244 
Touch evoked escape response 245 
Methods were adapted from Smith et al.
47
. Individual  freely-hatched embryos (48 hpf) were 246 
placed into a 6 cm diameter petri dish filled with clean embryo media at 28°C and were 247 
viewed under a JVC TH-C1480B colour camera connected to a desktop PC. Embryos were 248 
centred under the field of view and were filmed from prior to the onset of the 249 
mechanosensory stimulus. The mechanosensory stimulus was applied to the tail of the 250 
embryo using a blunt needle tip. Imaging ceased once the embryo had ceased swimming. Still 251 
images were taken throughout the touch response (every 25 frames), including the initial and 252 
final positions of the embryo. Images were then analysed using ImageJ
48
 to calculate distance 253 
travelled between consecutive images. Total distance travelled (mm) was then calculated. 254 
Four embryos from each of three treatment replicates were tested (n = 12).  255 
 256 
 257 
Hatching & growth  258 
Four replicates of each experimental treatment were screened at 24 h intervals to record the 259 
number of embryos hatched over the first 96 h of development (n = 4). Length and yolk-sac 260 
area was analysed as an indicator of growth at 24, 48 and 72 hpf. Four embryos from each of 261 
four treatment replicates were terminally anaesthetised using buffered MS-222 (0.08%). 262 
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Images of the embryos were taken using a Leica MZFIII photo-microscope and Leica Image 263 
Manager 50 and viewed using ImageJ
48
. The length of embryos, the distance from the most 264 
anterior part of the head to the tip of the tail following the path of the developing spinal 265 
cord
49
, and the area of the yolk-sac (including the yolk-extension) were measured (n = 16) at 266 
each time point. Embryos were dechorionated at 24 hpf to facilitate photography and 267 
morphometric analysis while freely-hatched embryos were used at 48 and 72 hpf.  268 
 269 
 270 
Cardiac development 271 
Single embryos (20 hpf) were placed into individual wells of a 96 well plate filled with 360 272 
µl of the appropriate concentration of prednisolone or control media. The entire plate was 273 
covered to prevent evaporation while it was maintained in an incubator at 25°C. Embryos 274 
were viewed at 1 h intervals over the course of 4 h and the percentage of embryos which 275 
displayed a visible heart beat was recorded. Maintaining embryos at 25°C reduced the rate of 276 
development and enabled any effect of prednisolone on the onset of heart beat to be 277 
highlighted. Four embryos from each of the six treatment replicates were used to calculate the 278 
percentage of embryos with a visible heart beat (n = 6). Heart rate was recorded at 24, 48 and 279 
72 hpf at 28°C. Individual embryos were visualised using a digital EUROMEX 6.0 M Pixel 280 
camera attached to a NOVEX Holland B-series microscope connected to a desktop PC. 281 
Embryos at 24 hpf were visualised within the chorion. At 48 and 72 hpf, freely-hatched 282 
embryos were mounted in a 6% methylcellulose solution on a microscope slide to maintain 283 
their position during recording. A drop of water was added on top of the methylcellulose to 284 
prevent desiccation during observation. Embryos were left to acclimate within the 285 
methylcellulose for 15 minutes prior to visualisation on top of a microscope slide heater to 286 
provide a constant temperature. An additional 1 minute acclimation period was provided 287 
while positioned on the microscope stage. Heart rate in beats per minute (bpm) was 288 
calculated as the mean number of beats during three 20 s periods, multiplied by three. Heart 289 
rate was measured using four embryos from three replicates of each treatment (n = 12).  290 
 291 
 292 
Metabolism 293 
Oxygen consumption was used as an indicator of metabolic rate and was measured using 294 
methods modified from Sloman
18
 at 24, 48 and 72 hpf. Oxygen consumption was measured 295 
using sealed respiratory chambers consisting of 20 ml blackened glass vials containing a 296 
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magnetic stirrer separated from the main body of the respirometer by a horizontal mesh 297 
partition. Magnetic fleas prevented an oxygen gradient forming within the chamber. Each 298 
respiratory chamber contained three embryos from the same replicate, and two respiratory 299 
chambers were tested for each of four treatment replicates (n = 8). Chambers were filled with 300 
system water and were maintained at 28±1°C in water baths. Water samples (0.1 ml) were 301 
taken from each chamber after a 4 h period and were immediately injected into a 302 
thermostatted cell (Strathkelvin Instruments, Glasgow, UK), containing an oxygen electrode 303 
connected to an oxygen meter. Embryos were then removed from the chambers and weighed 304 
on a balance. Calibration of the oxygen electrode used air-saturated water from the water 305 
baths as 100% saturation and a 2% solution of sodium sulphite (in 0.01 M sodium borate) as 306 
a 0% standard. The oxygen saturation values were then converted into µmol of oxygen which 307 
were adjusted for temperature and air-pressure and used to calculate mass specific oxygen 308 
consumption. Blank chambers served as controls to account for bacterial oxygen 309 
consumption.   310 
 311 
 312 
Skeletal muscle development 313 
Morphometric measurements were taken at 72 hpf. Anaesthetised embryos (0.04% MS-222) 314 
were visualised laterally under a dissection microscope attached to a EUROMEX 6.0 M Pixel 315 
camera connected to a desktop PC.  The area of the anal (AN), pre (PA) and post-anal (PSA) 316 
somites (Figure 1A) was calculated in addition to the angle connecting these segments. Six 317 
embryos from three treatment replicates were photographed (n = 18). Muscle integrity was 318 
visualised via birefringence using methods adapted from Smith et al.
47
. Polarised lens filters 319 
were positioned between the embryo and the microscope lens. The upper filter was then 320 
rotated to align both filters at 90° to eliminate any light which was not perpendicular to the 321 
muscle fibres (Figure 1B). The mean intensity of the skeletal muscle was divided by the area 322 
of muscle, and then normalized to control values. Four embryos were photographed from 323 
each of four treatment replicates (n = 16). All images were processed using Image J. 324 
 325 
 326 
Craniofacial morphogenesis 327 
Developmental changes to the anterior skeleton of embryos were investigated at 96 hpf.  328 
Embryos were euthanatized using an overdose of MS-222 (0.08%), fixed overnight at 4°C in 329 
4% phosphate-buffered formaldehyde, washed in PBS with 0.1% Tween-20 (PBT) and then 330 
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bleached in 3% hydrogen peroxide/ 1% potassium hydroxide. Embryos were then rinsed with 331 
PBT and transferred into 0.1% alcian blue solution (1% concentrated hydrochloric acid, 70% 332 
ethanol) and stained overnight. After rinsing several times with acidic ethanol (5% 333 
concentrated hydrochloric acid, 70% ethanol) embryos were rehydrated through an HCl-334 
EtOH series (75%, 50%, 25% and 0%) and stored in glycerol. Embryos were then 335 
photographed ventrally to capture the anterior portion of the developing skeleton using a 336 
EUROMEX 6.0 M Pixel camera (Figure 1C). Criteria for assessing skeletal development 337 
were adopted from Hillegass et al.
14
. The intercranial distance (ICD), lower jaw length (LJL), 338 
and ceratohyal cartilage length (CCL) were measured using ImageJ. Four embryos were 339 
photographed from each of four treatment replicates (n = 16). 340 
 341 
 342 
Swimming behaviour 343 
Swimming behaviour of individual embryos was assessed at 120 hpf in groups of five 344 
embryos which were placed into a 6 cm diameter petri dish marked with a grid floor (4.5 345 
mm
2
; approx. one body length) filled with clean embryo media (28°C). After an initial 2 346 
minute acclimation period within the dish, activity was recorded for 10 minutes. Behaviour 347 
was recorded using a JVC TH-C1480B colour camera positioned above the test chamber. The 348 
percentage of time spent swimming, distance swum (no. of body lengths swum; bls) and the 349 
average swim speed (body lengths per second; blsps) was calculated.  Five embryos were 350 
filmed from each of four treatment replicates (n = 20).  351 
 352 
 353 
Statistical analysis  354 
All statistical analysis was conducted using SPSS v.18. Data were checked for normality and 355 
homogeneity of variances using Kolmogorov-Smirnov and Levene’s tests, respectively. 356 
Where data were not normally distributed, or in the case of percentage data, transformations 357 
were conducted to allow parametric testing. No significant effect of replicate was found and 358 
so data were combined within treatments. Two-way ANOVAs were used to determine the 359 
effects of treatment and time on all measurements. Where significant interactions occurred 360 
within the ANOVA model, time and treatment effects were further analysed using one-way 361 
ANOVAs with Fisher’s LSD test post hoc. Non-parametric equivalents were used where 362 
necessary (Scheirer-Ray-Hare (SRH), Kruskal- Wallis test (KW) and pairwise Mann-363 
Whitney U).   364 
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 365 
 366 
Results 367 
 368 
Pre-hatch activity 369 
There was no significant difference in the onset of spontaneous contractions in response to 370 
prednisolone in pre-hatched embryos, however, all concentrations tested significantly 371 
reduced the frequency of spontaneous contractions at 24 hpf (Table 1, Figure 2A).  372 
 373 
Touch evoked escape response 374 
The touch-evoked escape response of freely-hatched embryos at 48 hpf increased following 375 
treatment with 0.1 µg/l of prednisolone (Table 1, Figure 2B).  376 
 377 
Hatching & growth 378 
Exposure to 1 and 10 µg/l prednisolone induced precocious hatching at 48 and 72 hpf (Table 379 
1, Figure 3), although prednisolone did not significantly alter length or yolk-sac area during 380 
embryogenesis. Mortality did not vary during the first 24 hours of development between 381 
treatments and no mortality was observed after this period.  382 
 383 
Cardiac development 384 
A significantly higher proportion of embryos exhibited a visible heart beat following 0.1 µg/l 385 
of prednisolone at 23 hpf, while 10 µg/l of prednisolone significantly reduced the onset of 386 
heart beat at 23 and 24 hpf (Table 1, Figure 4A). In contrast, heart rate was significantly 387 
increased by all concentrations of prednisolone between 24 and 72 hpf (Table 1, Figure 4B).  388 
 389 
Metabolism 390 
The rate of oxygen consumption between 24 and 72 hpf was significantly increased by all 391 
concentrations of prednisolone but at specific time points (Table 1, Figure 5).  392 
 393 
Skeletal muscle development 394 
The area of pre-anal somites were reduced in response to 0.1 µg/l of prednisolone, without 395 
affecting the angle of attachment between somites or the integrity of skeletal muscle (Table 396 
1).  397 
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 398 
Craniofacial morphogenesis 399 
There was also an overall enlargement of the cranial skeleton following 1.0 µg/l of 400 
prednisolone at 96 hpf, as all indices of craniofacial morphogenesis were significantly 401 
increased (Table 1, Figure 6).  402 
 403 
Swimming behaviour 404 
Finally, prednisolone significantly reduced the percentage of time embryos spent swimming 405 
(10 µg/l), the distance swum (0.1, 1.0 and 10 µg/l) and the average swim speed (1.0 and 10.0 406 
µg/l) at 120 hpf (Table 1, Figure 7). 407 
 408 
 409 
Discussion  410 
 411 
Exposure to environmental concentrations of prednisolone during embryogenesis resulted in 412 
significant physiological and behavioural effects throughout ontogeny. While the onset of 413 
spontaneous muscular contractions did not change in response to prednisolone treatment, the 414 
frequency of contractions were significantly reduced (Figure 2A). Exposure to 0.1 µg/l of 415 
prednisolone also increased the touch evoked escape response to a mechanosensory stimuli at 416 
48 hpf (Figure 2B). No effect of the higher concentrations of prednisolone on the escape 417 
response was observed and it may be prudent to interpret the fact that an effect was only seen 418 
at the lowest dose with caution. Regardless, zebrafish embryos which exhibit defects in 419 
skeletal muscle development are typically associated with a diminished escape response
47
 420 
which suggests that the developing musculature has not been negatively affected by 421 
prednisolone at this stage. Spontaneous contractions, as well as the startle response, are 422 
regulated by the neural circuitry within the spinal cord
50-53 
and the Mauthner neurons in 423 
particular are associated with regulating the escape response following mechanosensory 424 
stimulus
54
. Whether the neural circuitry has been altered in response to prednisolone however 425 
requires specific investigation.     426 
 427 
The increase in the percentage of embryos hatched following prednisolone treatment (Figure 428 
3) agrees with Wilson et al.
55
 who found that exposure to dexamethasone also resulted in 429 
precocious hatching in zebrafish embryos. Hatching is facilitated by a combination of 430 
14 
 
enzymatic digestion of the chorion and mechanical damage due to embryonic activity.
56
 431 
Since the frequency of pre-hatch activity significantly decreased, the increased hatching is 432 
more likely to be related to changes in the release of proteolytic enzymes. Cloud
57
 also 433 
hypothesised that exposure to exogenous steroids led to changes in the release of hatching 434 
enzymes. No statistically significant change in either length or yolk-sac area was found which 435 
suggests that growth was not detrimentally affected by prednisolone. This is in contrast to 436 
previous studies have shown diminished growth rates and reduced yolk-sac volumes in 437 
response to elevated glucocorticoid exposure.
19,20
  438 
 439 
The onset of heart contraction was significantly altered by prednisolone (Figure 4A). While 440 
the heart is the first organ to fully develop during vertebrate embryogenesis
58
, embryonic and 441 
early larval stages do not require a functional cardiovascular system for oxygen delivery
59
. 442 
The “prosynchronotropy” hypothesis proposes that the early onset of cardiovascular 443 
contraction is primarily related to cardiac morphogenesis
60
, which has been demonstrated 444 
experimentally by Hove et al.
61
. An earlier onset of heart contraction in response to 0.1 µg/l 445 
of prednisolone could therefore suggest an overall acceleration of cardiac development. 446 
However, exposure to 10 µg/l prednisolone also produced a delay in the onset of heart 447 
contraction. Biphasic physiological responses to xenobiotics are not uncommon although the 448 
precise underlying mechanisms are not clear, especially since both concentrations increased 449 
heart rate (Figure 4B). This could suggest that the developmental processes which regulate 450 
cardiogenesis and the physiological mechanisms which control heart rate are differentially 451 
regulated by glucocorticoids. Glucocorticoid signalling during early zebrafish ontogeny has 452 
been recently shown to significantly affect the structure and function of the heart in 453 
embryos.
62
 In addition, exposure to dexamethasone (100 µM) increases the size of embryonic 454 
hearts and enhances cardiac performance. Interestingly, injection of cortisol into zebrafish 455 
embryos causes heart deformities and suppression of essential cardiac genes.
63
 Wilson et al.
62
 456 
also found that zebrafish GR knockouts displayed diminished heart maturation. The intensity 457 
of glucocorticoid signalling therefore appears to differentially alter heart development and 458 
further study is necessary to elucidate the precise mechanisms of glucocorticoid mediated 459 
effects on cardiac development. 460 
 461 
Embryos exposed to prednisolone consumed more oxygen throughout the first 72 hours of 462 
development (Figure 5). This is in agreement with findings reported by Giesing et al.
17 
and 463 
Sloman
18
 and who found that exposure to endogenous glucocorticoids increased oxygen 464 
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consumption during embryonic development in stickleback (Gasterosteus aculeatus) and 465 
brown trout (Salmo trutta) respectively. The increase in oxygen consumption may be related 466 
to an increase in metabolic rate as glucocorticoids are essential regulators of metabolism in 467 
teleosts.
64
 Metabolic enzymes are sensitive to SG exposure during early development in 468 
zebrafish, e.g. phosphoenolpyruvate carboxykinase, which controls the rate limiting step in 469 
gluconeogenesis, increases in response to dexamethasone.
65
 Similarly, prednisolone (1 µg/l) 470 
is known to increase plasma glucose concentrations in adult fathead minnow.
11
 Increased 471 
metabolic rate could also accelerate organogenesis
66
 which is prioritised over growth during 472 
ontogeny
67
 and would facilitate an increase in hatching and heart maturation.  473 
 474 
Although there was an almost 10% reduction in birefringence in response to 10 µg/l of 475 
prednisolone, in a manner consistent with a myopathic phenotype
47
, no statistically 476 
significant difference between treatments was found. Nor were they any significant changes 477 
in the angle of attachment between adjacent somites. However, exposure to 0.1 µg/l of 478 
prednisolone resulted in significantly smaller pre-anal somites at 72 hpf. Given the relatively 479 
small change in the area of somites between treatments (approx. 5%), and no observable 480 
change in muscle integrity, the significance of these changes are likely to be minor since 481 
changes were localised to individual somites at specific concentrations of prednisolone. 482 
Swimbladder inflation was also unaffected by prednisolone treatment (data not shown) which 483 
suggests that this small change in somite size did not affect swim-up behaviour and is 484 
therefore likely to be physiologically insignificant.     485 
 486 
Craniofacial morphogenesis was significantly altered in response to 1 µg/l of prednisolone at 487 
96 hpf (Figure 6). Intercranial distance, LJL and CCL all increased, which suggests an overall 488 
enlargement of the cranial skeleton. Prednisolone has previously been shown to induce bone 489 
loss in zebrafish embryos but at far greater concentrations than those utilised in this study.
68
 490 
Dexamethasone also significantly alters craniofacial development in zebrafish embryos by 491 
altering the expression of MMPs which culminates in significantly longer heads.
13,14
 Whether 492 
prednisolone may also affect axial skeletal development requires additional investigation, 493 
however, it is unlikely that the increase in skull size led to the observed changes in swim 494 
behaviour, since 0.1 µg/l and 10 µg/l of prednisolone also caused behavioural effects, despite 495 
failing to alter skeletal development.  496 
 497 
 498 
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Embryos at 120 hpf exhibited significantly reduced swim activity in response to prednisolone 499 
treatment (Figure 7). This coincides with behavioural changes in response to dexamethasone 500 
exposure
69
 and from studies which have prevented normal glucocorticoid signalling during 501 
zebrafish development
26,55
. Reductions in spontaneous activity during pre-hatch and free-502 
swimming stages could suggest common physiological mechanisms may be susceptible to 503 
prednisolone throughout development. Alternatively, changes during early ontogeny may 504 
persist into free swimming stages. It may also be possible that higher concentrations of 505 
prednisolone may affect additional physiological systems which regulate behaviour; 506 
increasing concentrations of prednisolone produced differences in the swim profile of free 507 
swimming embryos. 508 
 509 
Given the parity between these findings and those from previous studies which have 510 
investigated glucocorticoid signalling during zebrafish ontogeny, we tentatively hypothesis 511 
that prednisolone toxicity may be primarily mediated through binding to the glucocorticoid 512 
receptor and subsequent modulation of glucocorticoid regulated pathways. Glucocorticoid 513 
signalling is responsible for regulating hundreds of genes; knockout of the maternally derived 514 
gr mRNA results in several developmental abnormalities within neural, vascular and visceral 515 
tissues.
37
 Exposure to SGs during early development may similarly interfere with multiple 516 
processes and would therefore suggest multiple molecular pathways may be responsible for 517 
the observed developmental changes. However, commonality with such studies may point to 518 
disruption to the hypothalamic-pituitary-interrenal (HPI) axis, which controls the release of 519 
cortisol and thereby regulates homeostasis
12
, as a logical starting point for future 520 
investigation. Cortisol is known to mediate several essential physiological processes such as 521 
metabolism and growth during early life stages. In addition, the persistent behavioural 522 
changes throughout development observed in this study also bear semblance to how changes 523 
in cortisol levels affect the neurological programming of individuals and subsequent 524 
behavioural phenotypes.
70,71
 Glucocorticoids are believed to serve an active role during 525 
neurogenesis
70,71 
and could have subsequent effects on brain monoamines
72
 which are 526 
important neural regulators of behavioural phenotypes in zebrafish
73
. 527 
 528 
 529 
The results from this study (summarised in Table 2) contribute to the growing body of 530 
evidence that SGs can alter several physiological processes during early development in fish, 531 
in a manner consistent with the effects of endogenous glucocorticoid signalling. Such 532 
17 
 
changes may have significant consequences upon the future development, performance and 533 
survival of zebrafish. Further investigations are therefore required to identify the underlying 534 
mechanisms for these changes during development and the potential long term implications 535 
also need to be clarified. 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
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 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
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Table legends 763 
 764 
Table 1: Summary of statistical analysis for all parameters measured. P values in bold 765 
indicate significant effects.  766 
 767 
Table 2: Summary of significant developmental effects following prednisolone treatment. ↓ 768 
indicates statistically significant decrease compared to controls; ↑, significant increase 769 
compared to controls; -, no significant change. ICD, intercranial distance; LJL, lower jaw 770 
length; CCL, ceratohyal length; hpf, hours post fertilisation. 771 
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Figure legends 793 
 794 
Figure 1: (A) Control embryo (72 hpf) showing somites analysed for morphometric analysis, 795 
pre-anal (PA), anal (AN) and post-anal (PSA). (B) Control embryo (72 hpf) under polarized 796 
light. Scale bars = 0.5 mm. (C) Control embryo at 96 hpf stained with 0.1% alcian blue. 797 
Numbers correspond with defined parameters; 1, lower jaw length (LJL); 2, intercranial 798 
distance (ICD); 3, ceratohyal cartilage length (mm). Parameters 1 and 3 begin from the 799 
dashed line. Scale bar = 250 µm.   800 
 801 
Figure 2: (A) Mean number of spontaneous contractions per minute at 24 hpf (n = 16). 802 
Letters denote significant differences between treatments at specific time points (P < 0.05). 803 
Where bars share letters there is no significant difference. Means ± SEM. (B) Distance 804 
travelled during touch invoked escape response at 48 hpf (n = 12). Letters denote significant 805 
differences between treatments (P< 0.05). Means ± SEM. 806 
  807 
Figure 3: The percentage of hatched embryos over the first 96 h of development (n = 4).  808 
Letters denote significant differences between treatments at specific time points (P < 0.05). 809 
Where bars share letters there is no significant difference. Means ± SEM. 810 
 811 
Figure 4: (A) The percentage of embryos which displayed a visible heart beat during the first 812 
25 h of development in response to prednisolone (n = 6). (B) Heart rate (beats per minute, 813 
bpm) of embryos at 24, 48 and 72 hpf in response to prednisolone (n = 16).  Letters denote 814 
significant differences between treatments at specific time points (P < 0.05). Where bars 815 
share letters there is no significant difference. Means ± SEM. 816 
 817 
Figure 5: The oxygen consumption (µmol.g
-1
h
-1
) of embryos at 24, 48 and 72 hpf in response  818 
to prednisolone (n = 8).  Letters denote significant differences between treatments at specific  819 
time points (P < 0.05). Where bars share letters there is no significant difference. Means ± 820 
SEM. 821 
 822 
Figure 6: Craniofacial measurements (mm) at 96 hpf (n = 16). Letters denote significant 823 
differences between treatments at specific time points (P < 0.05). Where bars share letters 824 
there is no significant difference. Means ± SEM. 825 
26 
 
 826 
Figure 7: (A) Percentage of time swimming at 120 hpf (n = 20). (B) Activity (number of body 827 
lengths swum) at 120 hpf (n = 20). (C) Average swim speed at 120 hpf (n = 20). Letters 828 
denote significant differences between treatments (P< 0.05). Means ± SEM. 829 
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Table 1 856 
 857 
 858 
 859 
 860 
 861 
 862 
 863 
Developmental 
endpoints 
 Test Test statistic P-value 
Pre-hatch activity Onset ANOVA F4, 19 = 0.424 P = 0.789 
 Frequency ANOVA F4,79= 7.268 P < 0.001 
Touch evoked escape 
response 
 ANOVA F4,56= 3.437 P = 0.016 
Hatching & growth Hatching 2-Way ANOVA 
Time, F1, 39 = 280.154 
Treatment, F4, 119  = 13.206 
Time*Treatment, F4, 39=  4.279 
P < 0.001 
P < 0.001 
P = 0.007 
 Length 2-Way ANOVA 
Treatment, F4, 230 = 1.865 
Time, F2, 230 = 174.667 
Treatment*Time, F8, 230 = 0.822 
P = 0.118 
P < 0.001 
P = 0.584 
 Yolk-sac area 
Scheirer-Ray-
Hare test 
Treatment, F4, 231, = 8.574 
Time, F2, 231 = 89.84 
Treatment*Time, F8, 231 = 4.577 
P = 0.373 
P < 0.001 
P = 0.805 
Cardiac development 
Onset of heart 
beat 
2-Way ANOVA 
Time, F1, 60  = 82.147 
Treatment, F 4, 60 = 11.532 
Time*Treatment, F 4, 60 = 4.557 
P < 0.001 
P < 0.001 
P = 0.003 
 Heart rate 2-Way ANOVA 
Time,  F1, 119 = 527.366  
Treatment, F4, 119 = 26.055 
Time*Treatment, F4, 119= 2.571 
P < 0.001 
P < 0.001 
P = 0.042 
Metabolism 
Oxygen 
consumption 
2-Way ANOVA 
Time, F2, 119 = 30.586 
Treatment, F4, 119 = 8.667  
Time*Treatment, F8, 119 = 8.667 
P < 0.001 
P < 0.001 
P < 0.001 
Skeletal muscle 
development 
Area of somites ANOVA 
Pre-anal, F4, 89 = 2.547 
Anal, F4, 89 = 1.148  
Post-anal, F4, 89 = 2.954 
P = 0.045 
P = 0.340 
P = 0.024 
 
Angle of 
attachment 
ANOVA 
Pre-anal, F4, 89 = 1.047 
Anal, F4, 89 = 1.284  
Post-anal, F4, 89 = 1.747 
P = 0.388 
P = 0.283 
P = 0.147 
 Muscle integrity ANOVA F4, 74 = 0.363 P = 0.834 
Craniofacial 
morphogenesis 
 2-Way ANOVA 
Area, F2, 206 = 817.249  
Treatment, F4, 206 =10.098  
Area*Treatment, F8, 206 = 0.606 
P< 0.001 
P< 0.001 
P = 0.772 
Swimming behaviour Time swimming Kruskal-Wallis χ² (4) = 13.344 P = 0.01 
 Distance swum ANOVA F4, 97 = 16.258 P < 0.001 
 Swim speed ANOVA F4, 97 = 2.682 P = 0.036 
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Table 2 864 
 865 
 866 
 867 
 868 
 869 
 870 
 871 
  
 
 
Concentration of 
prednisolone (µg/l) 
Developmental 
endpoints 
 
 Stage of 
development 
(hpf) 
0.1  1.0 10.0 
Pre-hatch activity Onset  15, 16, 17 -,-,- -,-,- -,-,- 
 Frequency  24 ↓ ↓ ↓ 
Touch evoked escape 
response 
 
 
48 ↑ - - 
Hatching & growth Hatching  48, 72, 96 -,-,- -,↑,- -,↑,- 
 Length  24, 48, 72 -,-,- -,-,-, -,-,-, 
 Yolk-sac area  24, 48, 72 -,-,- -,-,-, -,-,-, 
Cardiac 
development 
Onset of heart beat 
 
23, 24, 25 ↑,-,- -,-,- ↓,↓,- 
 Heart rate  24, 48, 72 ↑,↑,- ↑,↑,↑ ↑,↑,↑ 
Metabolism 
Oxygen 
consumption 
 
24, 48, 72 -,↑,- ↑,↑,- ↑,↑,↑ 
Skeletal muscle 
development 
Area of somites Pre-anal 72 ↓ - - 
  Anal 72 - - - 
  Post-anal 72 - - - 
 
Angle of 
attachment 
 
72 - - - 
 Muscle integrity  72 - - - 
Craniofacial 
morphogenesis 
ICD 
 
96 - ↑ - 
 LJL  96 - ↑ - 
 CCL  96 - ↑ - 
Swimming behaviour Time swimming  120 - - ↓ 
 Distance swum  120 ↓ ↓ ↓ 
 Swim speed  120 - ↓ ↓ 
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